Loading company…
NeoRx develops and commercializes oncology medicines, including the chemotherapy agent Picoplatin.
Founded in 2007 and based in Washington, NeoRx Corporation, formerly Poniard Pharmaceuticals, is a biopharmaceutical company focused on oncology products. Its portfolio includes Picoplatin, a platinum-based chemotherapy agent for multiple cancer indications and treatment combinations, administered by two routes.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in